Consumer Association Urges Malaysia to Ban E-cigarettes to Prevent Nicotine Addiction among Children

Sep.25.2022
Consumer Association Urges Malaysia to Ban E-cigarettes to Prevent Nicotine Addiction among Children
Consumer group urges Malaysia to ban e-cigarettes to prevent nicotine addiction among children, citing health risks and easy access.

The Consumers Association of Penang in Malaysia is urging the Ministry of Health to immediately ban all electronic cigarette products to prevent a large number of children from becoming addicted to nicotine.


According to data from the World Health Organization, electronic cigarettes contain nicotine and other toxic substances, which have a significant impact on users who are exposed to second-hand aerosols. Nicotine is a highly addictive substance and there is evidence to suggest that non-smoking minors who use e-cigarettes are twice as likely to smoke traditional cigarettes later in life.


According to research by CAP, children in Malaysia are able to easily purchase cheap electronic cigarettes because sellers do not inquire about the buyer's age. Children as young as 8 years old can purchase vaping devices and multiple children may even share one.


Mohideen Abdul Kader, a member of the Consumers Association of Penang (CAP), stated in a letter that although electronic nicotine delivery systems were only commercialized in Malaysia in early 2015, the number of people using these products in the country has increased from 600,000 in 2016 to 1.2 million in 2019. The National Treatment Centre (University of Malaya in George Town) reported approximately 30 cases of e-cigarette-related poisoning from 2015 to 2020, with most occurring in children aged 1-4 who are at high risk of death after ingesting e-cigarette liquid.


In Malaysia, the incidence of childhood cancer among children under 15 is nearly 77.4 cases per one million. Several studies have shown an increasing risk of cancer among those who use electronic cigarettes, or vaping. A study published in February 2022 found that vapers faced a higher risk of cancer than non-smokers. Evidence also suggests that US males and females aged 18 and above with a history of vaping are at a higher risk of bladder and lung cancer compared to those who have never smoked. Preclinical studies on mice exposed to e-cigarette vapors have shown increased incidence of lung adenocarcinoma and bladder urothelial hyperplasia.


Moon-shong Tang, from the New York University School of Medicine, has commented that "users of e-cigarettes, regardless of their age, have a higher risk of developing cancer than non-users". He told Lancet Oncology that in order to control childhood cancer, Malaysia should "prohibit the sale of e-cigarettes to minors".


According to Subbarow, over 20 countries have banned the sale of electronic cigarette products, and other nations including Australia, Norway and Canada have also implemented restrictions.


Malaysia's Health Minister, Khairy Jamaluddin, has proposed the "2022 Tobacco and Vaping Control Bill," which will impose fines on individuals born on or after January 1st, 2007, who sell tobacco or e-cigarette products. The bill is aimed at curbing the usage of tobacco and vaping products among younger generations.


Statement:


The content of this article has been compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The compilation of this article is only intended for industry communication and research.


Due to limitations in the level of translation, the translated article may not fully reflect the original meaning. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign issues, statements, and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
VAPORESSO introduced the PRIX MTL pod system in August 2026 in two versions, Filter and NFC. The Filter version allows users to switch between a conventional drip tip and a filter tip, while the NFC version links interchangeable panels to matching on-screen animations. PRIX features a 2,600mAh battery, a 5.5ml pod, a 0.87-inch TFT display and a maximum output of 40W, alongside Dual Mesh Impact Pods capable of operating at two resistance and power configurations. VAPORESSO's French website lists MSRP at $39.99 for the Filter version and $49.90 for the NFC version.
Market
Aug.24 by 2Firsts Perspectives
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
The UK Reform Party has proposed limiting the number of dedicated vape shops in the country to around 1,000 as part of a plan to tighten oversight of vape retail channels. The proposal was put forward by Reform UK deputy leader and MP Lee Anderson. The plan remains a political proposal and has not become UK government policy, with no detailed legislation, implementation timeline or allocation rules announced.
Aug.10
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18